AVTX
Avalo Therapeutics Inc
15.00$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +141.9% | -100.0% | – | – | -22.9% | -100.0% | – | – | – | -100.0% | – | – | |
| – | -192.1% | – | – | -308.2% | – | +6,695.4% | +80.3% | -6.3% | -99.8% | +6.3% | – | – | |
| – | – | -94.2% | -845.7% | – | -89.1% | -5,730.5% | – | – | – | -128.8% | – | – | |
| – | +49.5% | +13.3% | +122.3% | +102.8% | -14.2% | +11.5% | +54.3% | -3.2% | -2.6% | +5.9% | +66.7% | – | |
| – | +7.2% | +19.4% | +41.5% | -8.1% | +7.2% | +24.5% | -6.3% | +7.1% | +10.8% | +11.1% | +16.6% | – | |
| – | +21.3% | +16.1% | +75.0% | +49.7% | -3.0% | -34.7% | -1.2% | +6.4% | +115.0% | +5.5% | +50.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -94.8% | – | – | -7.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -76.6% | -253.0% | – | – | – | – | – | – | – | |
| – | -212.5% | – | +0.0% | -300.0% | – | -93.0% | +100.0% | -31.3% | +1,081.8% | -90.8% | +50.0% | – | |
| – | – | – | – | -76.6% | -253.4% | – | – | – | – | – | – | – | |
| – | – | – | – | -76.6% | -252.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.